German Wireless Telecom Stock News

DB:8W50
DB:8W50Software

European Penny Stocks To Watch In December 2025

As the European markets continue to show signs of steady economic growth, with the pan-European STOXX Europe 600 Index ending 1.60% higher, investors are increasingly looking for opportunities in various sectors. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those seeking growth potential at a lower entry cost. Despite being considered a niche investment category today, penny stocks can still offer compelling opportunities when backed by strong...
XTRA:DKG
XTRA:DKGRetail REITs

Deutsche Konsum REIT (XTRA:DKG) Q4 FFO Turn Negative, Undermining Bullish Cash-Flow Narratives

Deutsche Konsum REIT-AG (XTRA:DKG) has just wrapped up FY 2025 with Q4 total revenue of €38.3 million and a net loss (excluding extra items) of €22.4 million, alongside negative Funds From Operations (FFO) of €9.9 million that will catch income-focused REIT investors’ attention. The company has seen quarterly revenue move from €25.6 million in Q1 2025 to €29.6 million in Q2 and €29.0 million in Q3 before reaching €38.3 million in Q4, while EPS swung from a modest €0.05 in Q1 to losses of €0.8...
BST:3WB
BST:3WBTransportation

Waberer's International Nyrt Leads 3 Undiscovered European Gems with Strong Metrics

In recent weeks, the European market has experienced mixed performance, with the pan-European STOXX Europe 600 Index ending slightly lower and major stock indexes showing varied results. Amidst these fluctuations and potential rate hikes from the European Central Bank, investors are increasingly on the lookout for small-cap stocks that demonstrate resilience and strong fundamentals. Identifying a good stock in this environment often involves focusing on companies with robust financial metrics...
XTRA:ACT
XTRA:ACTChemicals

Is AlzChem Group (XTRA:ACT) Quietly Recasting Its Growth Story Around Creatine Nutrition Demand?

In December 2025, AlzChem Group AG approved a roughly €120 million investment program to build a more automated creatine production plant and related infrastructure, with phased commissioning scheduled from the second half of 2027 to capture additional demand in sports, food, and health. The company links this capacity expansion to early triple-digit million euro annual sales potential from its Creapure® and Creavitalis® lines, underscoring how nutrition and wellness trends are reshaping its...